Sign in

CIK 0000885590

  • Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
Phone
+1 514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$258,894
in 1 filing, $259K under 10b5-1 plans

Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lenar Aimee J. −$259K President, US Pharma sold 10% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-10 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Shares withheld for taxes −839 $22.56 $19K 162,240
2022-03-03 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Shares withheld for taxes −6,926 $23.61 $164K 163,079
2022-02-27 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Option exercise +24,292 186,033
2022-02-27 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Shares withheld for taxes −10,279 $24.35 $250K 175,754
2022-02-27 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Shares withheld for taxes −2,743 $24.35 $67K 173,011
2022-02-27 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Shares withheld for taxes −3,006 $24.35 $73K 170,005
2022-02-27 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Option exercise · Restricted Share Units −24,292 $24.35 $592K 0
2022-02-14 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Grant or award · Restricted Share Units +24,292 0
2021-08-27 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Shares withheld for taxes −5,017 $28.95 $145K 161,741
2021-06-02 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Option exercise +60,345 $14.38 $868K 227,103
2021-06-02 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Option exercise +60,853 $15.32 $932K 287,956
2021-06-02 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Sale −121,198 $31.83 $3.9M 166,758
2021-06-02 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Option exercise · Non-Qualified Stock Options (right to purchase) −60,345 0
2021-06-02 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Option exercise · Non-Qualified Stock Options (right to purchase) −60,853 0
2021-03-11 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Shares withheld for taxes −796 $32.82 $26K 166,758
2021-03-10 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Shares withheld for taxes −21,960 $32.97 $724K 167,554
2021-03-08 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Option exercise +8,455 163,534
2021-03-08 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Grant or award +25,980 189,514
2021-03-08 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Option exercise · Restricted Share Units −8,455 0
2021-03-03 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Grant or award +36,250 155,079

Page 1 of 2 · 39 trades